B. S. Srinath

1.6k total citations
40 papers, 1.1k citations indexed

About

B. S. Srinath is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, B. S. Srinath has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in B. S. Srinath's work include Cancer survivorship and care (8 papers), Breast Cancer Treatment Studies (7 papers) and Nanoparticles: synthesis and applications (4 papers). B. S. Srinath is often cited by papers focused on Cancer survivorship and care (8 papers), Breast Cancer Treatment Studies (7 papers) and Nanoparticles: synthesis and applications (4 papers). B. S. Srinath collaborates with scholars based in India, Denmark and Saudi Arabia. B. S. Srinath's co-authors include Raghuram Nagarathna, Hongasandra Ramarao Nagendra, KS Gopinath, R. M. Raghavendra, Nalini Rao, H. S. Vadiraja, N Vanitha, BS Ajaikumar, K. S. Gopinath and M. Raghavendra Rao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

B. S. Srinath

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. S. Srinath India 14 563 295 285 243 203 40 1.1k
K. S. Gopinath India 15 389 0.7× 156 0.5× 147 0.5× 185 0.8× 112 0.6× 54 1.0k
Amy Spelman United States 20 521 0.9× 173 0.6× 275 1.0× 293 1.2× 204 1.0× 40 1.1k
Lisa M. Thornton United States 18 799 1.4× 137 0.5× 50 0.2× 245 1.0× 399 2.0× 22 1.6k
Caroline Hoffman United Kingdom 14 345 0.6× 337 1.1× 207 0.7× 257 1.1× 105 0.5× 36 1.2k
KS Gopinath India 10 374 0.7× 221 0.7× 190 0.7× 158 0.7× 117 0.6× 14 766
Deborah Garet United States 7 449 0.8× 194 0.7× 161 0.6× 211 0.9× 185 0.9× 8 764
Christina Weltz United States 16 293 0.5× 61 0.2× 96 0.3× 78 0.3× 203 1.0× 36 1.3k
Mary B. Walker United Kingdom 12 301 0.5× 60 0.2× 100 0.4× 130 0.5× 122 0.6× 17 716
Henrik Flyger Denmark 11 206 0.4× 95 0.3× 69 0.2× 54 0.2× 94 0.5× 17 842
Christina Seluzicki United States 15 462 0.8× 37 0.1× 232 0.8× 126 0.5× 73 0.4× 27 802

Countries citing papers authored by B. S. Srinath

Since Specialization
Citations

This map shows the geographic impact of B. S. Srinath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. S. Srinath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. S. Srinath more than expected).

Fields of papers citing papers by B. S. Srinath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. S. Srinath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. S. Srinath. The network helps show where B. S. Srinath may publish in the future.

Co-authorship network of co-authors of B. S. Srinath

This figure shows the co-authorship network connecting the top 25 collaborators of B. S. Srinath. A scholar is included among the top collaborators of B. S. Srinath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. S. Srinath. B. S. Srinath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bepari, Asmatanzeem, et al.. (2025). Eco-synthesized silver nanoparticles from Curcuma longa leaves: Phytochemical and biomedical applications. Next Nanotechnology. 8. 100249–100249. 1 indexed citations
3.
Sreekanthreddy, Peddagangannagari, et al.. (2025). Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancer. BMC Cancer. 25(1). 916–916.
4.
Shastry, Rajesh P., et al.. (2024). The effect of Clitoria ternatea L. flowers-derived silver nanoparticles on A549 and L-132 human cell lines and their antibacterial efficacy in Caenorhabditis elegans in vivo. SHILAP Revista de lepidopterología. 8. 100359–100359. 17 indexed citations
5.
Srinath, B. S., et al.. (2024). Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes. Translational Oncology. 45. 101957–101957. 3 indexed citations
6.
Rao, Karthik, et al.. (2024). The Chimeric Antero-Lateral Thigh Flap and Vastus Lateralis Muscle Flap for the Infratemporal Fossa Reconstruction in Oral Cancer Defects. Indian Journal of Otolaryngology and Head & Neck Surgery. 77(2). 897–904.
7.
Srinath, B. S., et al.. (2024). Lower expressions of MIR34A and MIR31 in colo-rectal cancer are associated with an enriched immune microenvironment. Pathology - Research and Practice. 263. 155656–155656.
8.
9.
10.
Hari, Parameswaran, et al.. (2024). Serial Step Sectioning for Pathologically Node-Negative Oral Cancer: Echelon Node Evaluation and Failure Analysis for pN0 Patients. Journal of Maxillofacial and Oral Surgery. 24(6). 1901–1907. 1 indexed citations
11.
Kumar, Rekha V., et al.. (2023). Syringocystadenocarcinoma Papilliferum of Thigh—a Rare Cutaneous Malignancy with Unusual Histology and Clinical Presentation. Indian Journal of Surgical Oncology. 14(4). 900–903. 3 indexed citations
12.
Selvam, Sumithra, et al.. (2023). A comparative analysis of clinicopathological features and survival between pre and postmenopausal breast cancer from an Indian cohort. Scientific Reports. 13(1). 3938–3938. 4 indexed citations
13.
Srinath, B. S., et al.. (2023). Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis. Breast Cancer Research and Treatment. 200(1). 139–149. 4 indexed citations
14.
Nair, Madhumathy G, et al.. (2020). miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis. Cancer Medicine. 9(15). 5587–5597. 23 indexed citations
15.
Srinath, B. S., et al.. (2020). Single Institution Experience of Postoperative Electron Beam Radiation Therapy in the Treatment of Keloids. Advances in Radiation Oncology. 6(2). 100596–100596. 6 indexed citations
16.
Prabhu, Jyothi S., Aruna Korlimarla, Krisha Desai, et al.. (2017). Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease. Translational Oncology. 10(4). 699–706. 5 indexed citations
17.
Nagarathna, Raghuram, et al.. (2009). Effects of yoga on symptom management in breast cancer patients: A randomized controlled trial. SHILAP Revista de lepidopterología. 2(2). 73–73. 109 indexed citations
18.
Vadiraja, H. S., M. Raghavendra Rao, Raghuram Nagarathna, et al.. (2009). Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: A randomized controlled trial. Complementary Therapies in Medicine. 17(5-6). 274–280. 136 indexed citations
19.
Rao, M. Raghavendra, Raghuram Nagarathna, Hongasandra Ramarao Nagendra, et al.. (2008). Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: A randomized controlled trial. Complementary Therapies in Medicine. 17(1). 1–8. 128 indexed citations
20.
Raghavendra, R. M., R Nagarathna, Hongasandra Ramarao Nagendra, et al.. (2007). Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. European Journal of Cancer Care. 16(6). 462–474. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. S. Gopinath Breakdown of academic impact, for papers by Amy Spelman Breakdown of academic impact, for papers by Lisa M. Thornton Breakdown of academic impact, for papers by Caroline Hoffman Breakdown of academic impact, for papers by KS Gopinath Breakdown of academic impact, for papers by Deborah Garet Breakdown of academic impact, for papers by Christina Weltz Breakdown of academic impact, for papers by Mary B. Walker Breakdown of academic impact, for papers by Henrik Flyger Breakdown of academic impact, for papers by Christina Seluzicki
Rankless by CCL
2026